PFE · News · 20260918N
Comirnaty Regulatory Approval
PFIZER INC · 2026-09-18 · Importance 31 · Surprise 42 · In source text
Health Canada authorized Pfizer and BioNTech’s Omicron XFG-adapted COMIRNATY vaccine for individuals aged 6 months and older. The 2026–2027 formulation targets the Omicron XFG lineage and aligns with public-health recommendations to match currently circulating variants. Pfizer Canada reported sufficient inventory for federal and provincial vaccination programs, with availability through various distribution channels in the coming days and weeks.
Key facts
- The authorized COMIRNATY vaccine will be available through various distribution channels in the coming days and weeks. source
- The updated COMIRNATY vaccine targets the Omicron XFG lineage for the 2026-2027 season. source
- Pfizer Canada has ensured sufficient inventory for federal and provincial vaccination programs. source
- Health Canada has authorized Pfizer and BioNTech’s Omicron XFG-adapted COMIRNATY® vaccine for individuals aged 6 months and older against COVID-19. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The authorized COMIRNATY vaccine will be available through various distribution channels in the coming days and weeks. |